Pan-Biome Pharmaceuticals

Pan-Biome is a preclinical biopharmaceutical company focused on age-related diseases and extending human healthspan. Pan-Biome's lead compound activates the anti-inflammatory cytokine IL-10 and inhibits the major pro-inflammatory cytokines TNF-a, IL-1b, and IL-6. These cytokines significantly contribute to inflammation in healthy older adults and also play a major role in age-related diseases. Pan-Biome's compounds also activate AMPK and Nrf2, which are key regulators of the aging process.